Firazyr 30 MG/3 ML syringe 3ML
Ended Awarded
- Contract number
- SPE2DB25FE3D3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,639
Award facts
- Contract value 100% obligated
- $19,638.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,638.87 to AmerisourceBergen Drug Corp for the supply of Firazyr 30 mg/3 ml syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025. The award was made on August 27, 2025, with performance to be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Firazyr is a pharmaceutical product used in the treatment of acute angioedema, and this delivery order represents a specific supply requirement within the Defense Health Agency's pharmaceutical procurement operations.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting military and veteran healthcare systems. The parent indefinite delivery contract serves as a global pharmaceutical support vehicle enabling the company to supply an extensive range of medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FE3D3?
SPE2DB25FE3D3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FE3D3 worth?
The government has obligated $19,639 on SPE2DB25FE3D3.
Is contract SPE2DB25FE3D3 an order under another contract?
Yes. SPE2DB25FE3D3 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE3D3 competed?
The extent of competition for SPE2DB25FE3D3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award